Central Compounding Network
Wholesale compounding for downtown Toronto pharmacies — with a B2B portal and USP-grade same-day delivery that only PHH can deliver.
500+ Toronto pharmacies can't fill compounded prescriptions — and they're losing the patient every time.
Building a Level B non-sterile compounding lab costs $500K+ in capital, plus 12+ months of regulatory approvals, plus ongoing hiring of skilled compounding pharmacists who are in scarce supply. Independent retail pharmacies can't justify it for the 10–30 compounded scripts they might see per month.
So they refer the patient to a large compounding wholesaler like Pace or MedisCa. Turnaround is 2–5 business days. The patient — who is often in pain or discomfort — loses trust, and the pharmacy loses the relationship. Meanwhile, the compounding market is dominated by a few national players with no incentive to offer same-day service in Toronto.
Pharmacies in Toronto urban core
~500
Addressable partner network
Avg compounded Rx referrals per pharmacy
10–30/mo
Currently lost to wholesalers or patients going elsewhere
Total monthly compounded Rx opportunity
5K–15K
Across the network
Avg compounded Rx value
$40–200
Retail; wholesale ~50% of retail
231 Dundas becomes the downtown compounding hub. Partner pharmacies place orders through a B2B portal. Same-day delivery.
Photon Health compounds centrally at 231 Dundas — Level B non-sterile, with the full range of dermatology, pediatric, pain, and hormone formulations. Partner pharmacies access a B2B portal to place orders, track batches in real time, and offer their own patients USP-grade same-day delivery. Partner pharmacy keeps the patient relationship and the retail margin. PHH keeps the wholesale margin and the network.
Partner Portal — Desktop Dashboard
B2B · Compounding Wholesale
partners.photonhealth.ca
PHH Compounding
Partner Portal
Menu
Partner
Queen St Pharmacy
Dashboard
Today's Orders
12
Orders today
3
In QA
5
Dispatched
4
Delivered
Active Orders
| Rx # | Patient | Compound | Status | ETA |
|---|---|---|---|---|
| #R-4821 | Pt M.K. | Tretinoin 0.05% cream 30g | Dispatched | 15 min |
| #R-4820 | Pt J.L. | Ketoprofen/Lidocaine cream | In QA | 45 min |
| #R-4819 | Pt A.T. | Amoxicillin 125mg/5ml susp | Preparing | 1h 20m |
| #R-4818 | Pt R.S. | Diclofenac 2% gel 50g | Delivered | Delivered |
| #R-4817 | Pt N.P. | Progesterone 100mg cap | Preparing | 2h 10m |
This month Rx
287
Avg turnaround
2h 14m
Same-day rate
96%
Partner places order
3 clicks
from order to confirmation
PHH compounds + QAs
Level B
USP-grade, 231 Dundas
Delivered same day
< 12 hrs
downtown Toronto
B2B order portal with pre-built formula catalog
Real-time batch tracking — preparing → QA → dispatched → delivered
USP-grade same-day delivery via dedicated courier, downtown Toronto
Custom formula request workflow for non-standard prescriptions
Volume analytics and Rx-level reporting per partner pharmacy
White-label patient-facing receipt / compounding certificate
Wholesale margin on every compounded Rx, scaled across a partner network.
Unlike standalone compounding wholesale, our margin is stacked: we earn wholesale on the compound AND retail on anything our own PHH pharmacies compound. And because we own the local delivery operation, we capture a meaningful service premium over shipping-based wholesalers.
Revenue Lines
Wholesale margin per Rx
30–50% depending on complexity and volume. Same-day delivery commands a ~20% premium on baseline wholesale pricing.
Recurring partner revenue
Partners place orders weekly once onboarded. Average monthly partner revenue ~$4,000–8,000 per pharmacy.
Portal SaaS (optional)
Small monthly fee (~$50–100/pharmacy) to access advanced reporting and priority support. Low-commitment recurring revenue.
Vertical integration into PHH retail
Same compounding lab serves our own PHH pharmacies at zero wholesale margin, but full retail margin.
Projections
Year 1 partner target
5 pharmacies
~30 Rx/month each
Year 1 network revenue
$144K
5 × 30 × $80 avg × 12 months
Year 3 network revenue
$1.5M
20 partners × 80 Rx/mo × $80 avg
Projections are directional and subject to validation against pilot performance and market conditions.
Location + capex + expertise. This isn't easy to copy.
A competitor would need to match three things simultaneously: a Level B compounding facility with $500K+ capex and 12-month regulatory lead time, a downtown Toronto location with last-mile delivery economics, and the compounding expertise our team has already developed over years at 55 Dundas.
Downtown Toronto location
231 Dundas is geographically ideal for same-day delivery across the urban core — a structurally hard-to-replicate advantage for any suburban or out-of-Toronto competitor.
Compounding expertise transferred from 55 Dundas
Our team has been compounding for years at the existing location. Regulatory and operational know-how is already in-house — no learning curve.
Partner network lock-in
Once a pharmacy integrates into our portal and builds operational rhythm around same-day delivery, switching costs are high and the margin we take is invisible to the patient.
Vertical integration
Our own PHH pharmacies are the anchor customer. We don't depend on partners to hit viability — partners are incremental margin on infrastructure we'd build anyway.
Milestones
Q3 2026
231 Dundas pharmacy opens; Level B compounding operational
Q4 2026
B2B portal MVP (order entry + batch tracking + delivery ETA)
Q1 2027
Onboard first 3–5 partner pharmacies in downtown core
2027
Scale to 20+ partners; expand coverage to midtown and east end; launch custom formula workflow
Interested in Central Compounding Network?
We're happy to walk through unit economics, share pilot data as it comes in, and discuss how this fits into the broader Photon Health Holdings thesis.